The RTM Market in 2026
March 28, 2026 · Mallard Research
The market has split
Remote Therapeutic Monitoring is no longer a niche. In 2026, it is a crowded market with a dozen credible vendors, new CPT codes added by CMS this year to lower the floor for shorter monitoring episodes, and a real revenue opportunity for practices willing to build the operational infrastructure.
The challenge is not finding a vendor. It is identifying which type of vendor matches how your practice actually operates. The RTM market has separated into three distinct camps: managed providers who run the program for you, enterprise software platforms built for health systems with internal bandwidth, and sensorless AI startups that eliminate the hardware problem entirely. Each camp solves a different constraint. None is universally correct.
Managed providers: RTM as a service
Managed RTM companies take on the operational work that most practices cannot absorb internally. They supply the clinical staff who review patient data daily, conduct outreach, generate documentation, and prepare billing-ready records. The practice collects the revenue without building a new department.
The major players in this camp differ mostly in focus and differentiation.
Limber Health built its reputation in PT-focused programs, with a library of 7,000-plus exercise videos and MIPS/QCDR support validated through a Mayo Clinic partnership. It was acquired by Net Health in early 2025 and is now the preferred RTM solution for WebPT and Clinicient users, with access to FOTO, the largest risk-adjusted rehab outcomes dataset in the industry. That consolidation changes the value proposition from standalone RTM software to integrated RTM-within-your-EHR.
Relay RTM takes a deliberately low-friction approach. It runs entirely over SMS, with no app download required. That makes it practical for patient populations that are less likely to engage with a mobile app, and it extends naturally into specialties beyond orthopedics and MSK: oncology, rheumatology, neurology, pain management.
PhyxUp Health is PT-founded and Harvard-affiliated. Its AI-generated SOAP notes are the standout feature, with reported documentation time reductions around 60% and patient engagement rates above 80%. For practices where clinician time is the binding constraint, that matters more than any feature in the software itself.
1bios differentiates on compliance confidence. Its clinical staff are U.S.-based without exception, it handles device logistics end-to-end, and it reports 100,000-plus patients served with zero compliance failures. For practices that have been burned by offshore staffing arrangements or billing irregularities, that track record is the product.
KangarooHealth covers the widest code range of any managed provider in the market, handling not just RTM but RPM, CCM, PCM, TCM, and APCM under one contract. For practices that want a single vendor relationship across multiple CMS monitoring programs, that breadth is a real operational advantage. Enrollment runs in 24 to 48 hours, and its clinical staff are multilingual.
Mallard Medical is built around interoperability. Rather than tying practices to a specific device or data source, it integrates with any data provider, allowing each to plug in without replacing what is already working. Licensed clinicians handle daily review, and billing-ready documentation is generated automatically. The emphasis is on letting practices choose the best software for their clinical context while keeping the monitoring infrastructure and audit trail consistent underneath.
Enterprise platforms: for practices that already have the staff
Enterprise RTM platforms are software tools, not turnkey services. They assume the practice has clinicians who will do the monitoring work and want a platform that fits inside existing workflows.
Force Therapeutics is the clearest example. It integrates directly with Epic and Cerner, includes built-in provider timers, and offers cohort-level monitoring dashboards with a "manage by exception" view designed for high-volume surgical centers. For a large orthopedic group running hundreds of patients through joint replacement pathways simultaneously, that architecture makes the monitoring workload manageable without adding headcount.
MedBridge is used by more than 3,500 organizations and embeds RTM enrollment inside the home exercise prescription workflow that clinicians are already completing. One-click enrollment means RTM becomes a byproduct of HEP documentation rather than a separate administrative task. The company has published concrete revenue examples, including a practice generating $43,785 in new revenue from tracking HEP engagement the practice was already prescribing.
Zimmer Biomet's mymobility platform is built around the joint replacement surgical relationship. It captures stairs climbed, VO2 max, heart rate variability, and narcotic tracking in the post-surgical period. In December 2025, Zimmer announced an exclusive integration with OneStep, adding passive gait analysis to the data it collects. For orthopedic surgeons already inside the Zimmer implant ecosystem, the platform offers a unified post-surgical monitoring pathway without procurement complexity.
Net Health, following its 2025 Limber acquisition and its January 2026 acquisition of Keet from WebPT, now occupies an unusual position: it has both a managed service layer (Limber) and enterprise software capabilities (Keet, integrated with WebPT and Clinicient), with the FOTO outcomes database underneath. Practices that want the option to shift between managed and self-managed over time have an argument for this ecosystem.
Sensorless AI: the hardware-free alternative
The sensorless camp solves a problem that managed and enterprise platforms largely ignore: patients do not reliably wear or charge wearables. Two companies have built clinically validated alternatives.
OneStep uses the accelerometer and gyroscope already inside any smartphone to extract more than 30 gait parameters and 15 functional assessments. The patient puts the phone in their pocket and walks. No wearable, no app interaction required during the assessment. Peer-reviewed validity studies report intraclass correlation coefficients of 0.92 to 1.0 for cadence and gait speed against reference standards. Zimmer Biomet's exclusive integration agreement with OneStep reflects how seriously enterprise buyers are treating this capability.
Exer Health uses a standard 2D phone or tablet camera to generate real-time 3D kinematic models, range-of-motion measurements, and spatiotemporal gait analysis during telehealth visits. Any telehealth encounter becomes an objective clinical data collection event. No additional hardware, no patient compliance burden.
Both companies are positioned primarily as data capture and analysis layers rather than full RTM program operators. They are likelier to appear as integrations within managed or enterprise solutions than as standalone programs.
Matching the camp to your practice
The decision is less about which vendor has the best feature set and more about where your operational constraint actually sits.
If your practice lacks the clinical bandwidth to run a monitoring program internally, a managed provider removes that barrier entirely. The revenue is lower per patient because the vendor takes a margin, but the program runs.
If you have the staff, existing EHR infrastructure, and patient volume to justify a software-only approach, enterprise platforms offer more control and integration depth.
If patient engagement and hardware compliance are your biggest failure modes, sensorless AI removes the wearable problem from the equation and may work as a layer on top of whichever program structure you choose.
The 2026 CPT additions make shorter monitoring episodes reimbursable for the first time. That changes the calculus for practices that previously concluded RTM was only viable for longer post-surgical windows. The market, and the reimbursement infrastructure underneath it, is still expanding.